# A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer

> **NCT07673419** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Geekgene Technology Co., LTD** · enrollment: 10 (estimated)

## Conditions studied

- Advanced Lung Cancer

## Interventions

- **DRUG:** GK01 Injection

## Key facts

- **NCT ID:** NCT07673419
- **Lead sponsor:** Beijing Geekgene Technology Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2028-06
- **Final completion:** 2028-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07673419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07673419, "A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07673419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*